FLAMMA is a Family Owned & Run CDMO that provides small molecule CMC services to innovator companies. Specializing in the cGMP manufacturing of APIs, NCEs, RSMs and Advanced intermediates (NCEs and generics), Flamma provides a stable, reliable supply chain by leveraging our 100% self-owned, self-managed facilities, in Italy, China and the USA.

FLAMMA has ~850 employees across its five cGMP manufacturing facilities:

Italy
Flamma Chignolo (120 m3)
Flamma Isso (130 m3)
Flamma Bulciago (650 m3)

China
Flamma Honkai, Dalian (200 m3; 400 m3 by 2025)

USA
Flamma USA is located in Malvern, PA (near Philadelphia)
cGMP Pilot Plant, cGMP kilo labs (5), cGMP HPAPI kilo lab (1)

FLAMMA works with pharmaceutical companies ranging from virtual to large pharma/biotech companies who are working on early stage pre-clinical development of small molecules (multi-kilo) all the way to large-scale commercial manufacturing (MT). For many of these, Flamma is part of their preferred supplier network. Find out why Flamma is the “go to” contract manufacturer of the pharma industry.

Follow Flamma on LinkedIn at https://www.linkedin.com/company/flamma-spa/

FLAMMA- The Thinking CDMO™
http://www.flammagroup.com